Biography
Dana Delott is a senior attorney in our Dallas office. Her clients range from start-ups to large multinational and Fortune 500 companies. She has experience in full cycle advice and representation in temporary and permanent immigration categories including: B-1/B-2 (visitors), F-1 (students), H-1B (temporary professional workers), J-1 (exchange visitors), K-1 (fiancé), L-1 (intracompany transferees), O-1 (extraordinary ability), TN (NAFTA), EB-1 (extraordinary ability, multinational executives/managers, and outstanding professors/researchers), EB-2 (advanced degree, including national interest waivers), relative petitions, and removal of conditions, among many others.
Dana has extensive experience with adjustment, change, and extension of status requests. Her work includes complex naturalization (citizenship) matters and citizenship through derivation. Dana has advised and mitigated the immigration consequences of immigration law violations and criminal charges, including inadmissibility waivers and Nunc pro tunc late-filed requests. She has successfully represented clients in responding to Requests for Evidence (RFE), and filing Motions to Reopen/Reconsider (MTR). Dana’s family-based work spans the full range of relative case options for family members within the US and abroad. She has represented individuals with immigration options for children born abroad through ART (surrogacy), as well complex post-divorce removal of conditions and step-parent petitions.
Dana has significant experience with skilled and professional workers, multinational executives and specialized knowledge employees, professors and researchers, entrepreneurs, and health care providers. She also assists corporate clients with merger and acquisition related immigration consequences and requirements. She has counseled for profit and non-profit entities across industries including IT, biotech, pharmaceutical, engineering, manufacturing, architecture, construction, higher education, public/private K-12 schools, financial institutions, hedge funds and brokerages, research institutions, hospitals, medical and dental practices, pharmacies, and law firms.